Aripiprazole Lauroxil for Preventing Psychotic Relapse After an Initial Schizophrenia Episode

Conditions:   Schizophrenia;   Schizoaffective Disorder, Depressive Type;   Schizophreniform Disorder Interventions:   Drug: Aripiprazole Lauroxil;   Drug: ARI-ORAL;   Drug: AL-NCD Sponsors:   University of California, Los Angeles;   Alkermes, Inc. Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials